tradingkey.logo
搜索

Neogenomics Inc

NEO
添加自选
14.970USD
+0.380+2.60%
收盘 07/01, 16:00美东报价延迟15分钟
1.94B总市值
亏损市盈率 TTM

关于 Neogenomics Inc 公司

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Neogenomics Inc简介

公司代码NEO
公司名称Neogenomics Inc
上市日期Dec 10, 2012
CEOZook (Antony P)
员工数量2200
证券类型Ordinary Share
年结日Dec 10
公司地址9490 Neogenomics Way
城市FORT MYERS
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编33912
电话12397680600
网址https://neogenomics.com/
公司代码NEO
上市日期Dec 10, 2012
CEOZook (Antony P)

Neogenomics Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
220.01K
+0.96%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
164.03K
+3.45%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
75.42K
+30.60%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
51.18K
+45.09%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
30.24K
+76.32%
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
22.96K
--
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alison L. Hannah, M.D.
Dr. Alison L. Hannah, M.D.
Independent Director
Independent Director
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
220.01K
+0.96%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
164.03K
+3.45%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
75.42K
+30.60%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
51.18K
+45.09%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
30.24K
+76.32%
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
22.96K
--

常见问题

Neogenomics Inc的前五大股东是谁?

Neogenomics Inc 的前五大股东如下:Mr. Jeffrey Scott (Jeff) Sherman

有多少机构持有Neogenomics Inc(NEO)的股份?

截至2026Q1,共有564家机构持有Neogenomics Inc的股份,合计持有的股份价值约为156.61M,占公司总股份的120.32%。与2025Q4相比,机构持股有所增加,增幅为7515333.00。

哪个业务部门对Neogenomics Inc的收入贡献最大?

在2026Q1,Clinical Services-Client direct billing业务部门对Neogenomics Inc的收入贡献最大,创收518.84M,占总收入的71.34%。